Search for a report

GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

The global glucose monitoring system market is bifurcated into self-monitoring of blood glucose (SMBG) market and continuous glucose monitoring system market (CGMS). The SMBG market is anticipated to grow to $23395.5 million by 2028 at a CAGR of 5.22% between 2019 and 2028, whereas the CGMS market is anticipated to grow to $8642.3 million by 2028, at a CAGR of 22.31% between 2019 and 2028. Traditionally, CGMS faced competition from finger-based self-monitoring blood glucose (SMBG) devices, which are cheaper, easy-to-use, and easily approved by the authorities.

GLOBAL GLUCOSE MONITORING SYSTEM MARKET FORECAST 2019-2028

Global Glucose Monitoring System Market by Component Type (Sensors, Transmitters and Receivers, Insulin Pump) by End-users (Home Settings, Diagnostics and Clinics, Hospitals) by Demographics (Adult Population (>14years), Child Population (≤14years)) by Component Type (Test Strips, Glucose Meter, Lancets) by End-user (Home Settings, Clinical, Hospital) by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) by Geography.

Request free sample

The global glucose monitoring system market is bifurcated into self-monitoring of blood glucose (SMBG) market and continuous glucose monitoring system market (CGMS). The SMBG market is anticipated to grow to $23395.5 million by 2028 at a CAGR of 5.22% between 2019 and 2028, whereas the CGMS market is anticipated to grow to $8642.3 million by 2028, at a CAGR of 22.31% between 2019 and 2028. Traditionally, CGMS faced competition from finger-based self-monitoring blood glucose (SMBG) devices, which are cheaper, easy-to-use, and easily approved by the authorities.

The factors augmenting the global glucose monitoring system market growth are:

  • A rise in the incidence of diabetes
  • Awareness among the general population
  • Increasing CGMS and SMBG affordability
  • Technological advances in GMS devices
  • Increase in healthcare expenditure
  • Increasing focus on research and development
  • Technology integration

Glucose-Monitoring-System-Market

To know more about this report, request a free sample copy

The important drivers increasing growth in the global glucose monitoring system market are the rise in the incidence of diabetes and increasing CGMS and SMBG affordability. Changing eating habits, lifestyles, and reduced bodily workout have led to a surge in obesity, which is the chief cause of type 2 diabetes in grown-ups. SMBG is relatively inexpensive, easy, provides an accurate measure of capillary glucose concentrations, and the available glucose meters can offer features including memory, downloading software, no coding strips, and small blood sample requirements.

In 2019, the sensors category was the dominating category in CGMS by component type segment, contributing 68.59% of the market share, and the transmitter and receivers category is anticipated to be the fastest-growing component type, registering a CAGR of 26.01% by the end of the forecast period. The sensors can provide signals to display the real-time glucose levels of the patients. Transmitters and receivers are sold as standalone systems as well as single units.

Also, in 2019, around 78.15% of the revenue share was captured by the test strips category in terms of SMBG by component type, and the lancets category is anticipated to grow at a faster rate during the forecast period. The lancet is a blood sampling device to be used only once, and then disposed of in a safe way.

Lack of awareness of the diagnostic opportunities and inaccuracy in the reading of GMS devices are the major factors hindering the glucose monitoring system market growth. Since there is no easy way to assess the education materials/training courses for patients as well as diabetologists, it is difficult to put together comprehensive advice for therapeutic optimization. This leads to a lack of awareness of the diagnostic opportunities provided by CGMS, in turn, impacting the overall growth of the CGMS market. Meter calibration, variables in test strips, environmental conditions, improper meter maintenance, and user error in coding, are other major factors leading to inaccuracy in readings.

The report on the global glucose monitoring system market includes the segmentation analysis component type, demographics, application, and end-user.

  • CGMS market by Component Type:
    • Sensors
    • Insulin pump
    • Transmitters and receivers
  • CGMS market by End-users:
    • Home settings
    • Hospitals
    • Diagnostics and clinics
  • CGMS market by Demographics:
    • Child population (≤ 14years)
    • Adult population (> 14years)
  • SMBG market by Component Type:
    • Lancets
    • Test Strips
    • Glucose meter
  • SMBG market by End-users:
    • Hospitals
    • Home settings
    • Clinics
  • SMBG market by Application:
    • Type 2 diabetes
    • Type 1 diabetes
    • Gestational diabetes

Geographically, the global glucose monitoring system market has been segmented based on four major regions, which includes:

  • North America: the United States and Canada
  • Asia Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Australia, Philippines, and Rest of Asia Pacific
  • Europe: Germany, the United Kingdom, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Rest of World: Latin America, the Middle East & Africa

In 2019, the North America region dominated the CGMS and SMBG market with a revenue share of approx. 61.15% and 39.51%, respectively, and the Asia Pacific region is anticipated to be the fastest-growing region. The glucose monitoring system market in North America is witnessing significant growth, primarily because of the growing prevalence of obesity as well as diabetes. This has raised the demand for GMS devices and services in the region.

 Furthermore, in the past two decades, China has become one of the most powerful economies in the world and is currently the biggest consumer market in the world. China is one of the biggest prospective markets for the business of medical devices, and CGMS has substantial growth possible in China.

The well-known market players of the global glucose monitoring system market are:

  • Abbott
  • Glysens Inc
  • Roche Diagnostics
  • Dexcom
  • Tandem Diabetes Care
  • Others

Key strategies adopted by some of the glucose monitoring system companies are:

In April 2020, Abbott announced CE Mark has been received by its TriClip Repair System and is now accepted for use in Europe and some other countries that distinguish CE Mark as a treatment of non-surgical for people. In October 2019, Dexco Inc. announced that the Food and Drug Administration (FDA) has cleared the G6 Pro Continuous Glucose Monitoring System of Dexcom for healthcare specialists to use with the patients, ages two years and above.

Key findings of the global glucose monitoring system market are:

  • CGMS market is anticipated to be the fastest-growing market during the forecast period.
  • The development of high-quality wearable devices is driving the market.
  • Mobile healthcare is making devices more user-friendly.
  • Self-monitoring of blood glucose is an extremely lucrative business with huge market opportunities.
  • Major companies are collaborating to develop integrated CGMS-enabled insulin pumps.
  • There is an increase in the use of non-invasive devices for continuous glucose monitoring.
  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARIES
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • RISE IN THE INCIDENCE OF DIABETES
      • INCREASE IN HEALTHCARE EXPENDITURE
      • INCREASING FOCUS ON RESEARCH AND DEVELOPMENT
      • TECHNOLOGY INTEGRATION
      • INCREASING CGMS AND SMBG AFFORDABILITY
      • TECHNOLOGICAL ADVANCES IN GMS DEVICES
      • AWARENESS AMONG THE GENERAL POPULATION
    •    KEY RESTRAINTS
      • HINDRANCE FROM GOVERNMENT REGULATIONS
      • INADEQUATE REIMBURSEMENT OPTIONS FOR CONTINUOUS GLUCOSE MONITORING DEVICES
      • LACK OF AWARENESS OF THE DIAGNOSTIC OPPORTUNITIES
      • INTENSE COMPETITION AMONG VENDORS
      • INACCURACY IN READING OF GMS DEVICES
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCE ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • KEY BUYING CRITERIA
    • REGULATION OF BLOOD SUGAR
    • VALUE CHAIN ANALYSIS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. CGMS MARKET BY COMPONENT TYPE
    • SENSORS
    • TRANSMITTER AND RECEIVERS
    • INTEGRATED INSULIN PUMPS
  3. CGMS MARKET BY END-USER
    • HOME SETTINGS
    • DIAGNOSTICS AND CLINICAL
    • HOSPITAL
  4. CGMS MARKET BY DEMOGRAPHICS
    • ADULT POPULATION (>14YEARS)
    • CHILD POPULATION (≤14YEARS)
  5. SMBG MARKET OVERVIEW
  6. SMBG MARKET BY COMPONENT TYPE
    • TEST STRIPS
    • GLUCOSE METER
    • LANCETS
  7. SMBG MARKET BY END USER
    • HOME SETTINGS
    • CLINICAL
    • HOSPITAL
  8. SMBG MARKET BY APPLICATION
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
    • GESTATIONAL DIABETES
  9. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      •    THE UNITED STATES
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      •    CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
    •    EUROPE
      •    GERMANY
        • GERMANY HEALTH AND HEALTHCARE
        • GERMANY PHARMACEUTICAL MARKET
      •    THE UNITED KINGDOM
        • THE UNITED KINGDOM HEALTH AND HEALTHCARE
        • THE UNITED KINGDOM HEALTHCARE PROVISION
        • THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
        • THE UNITED KINGDOM PHARMACEUTICALS
      •    FRANCE
        • FRANCE HEALTH AND HEALTHCARE
        • FRANCE HEALTHCARE PROVISION
      •    RUSSIA
        • RUSSIA HEALTH AND HEALTHCARE
        • RUSSIA PHARMACEUTICAL SERVICES
      •    ITALY
        • ITALY HEALTH AND HEALTHCARE
        • ITALY HEALTHCARE PROVISION
        • ITALY PHARMACEUTICAL MARKET
      • BELGIUM
      • POLAND
      • REST OF EUROPE (ROE)
    •    ASIA PACIFIC
      •    CHINA
        • CHINA HEALTH AND HEALTHCARE
        • CHINA PHARMACEUTICAL MARKET
        • CHINA DIABETES MARKET
        • MARKET TRENDS
      •    INDIA
        • INDIA HEALTH AND HEALTHCARE
        • INDIA REGULATORY CHANGES
        • INDIA PHARMACEUTICAL MARKET
        • INDIA DIABETES MARKET
      •    AUSTRALIA
        • MARKET TRENDS
      •    JAPAN
        • JAPAN HEALTH AND HEALTHCARE
        • JAPAN PHARMACEUTICAL MARKET
        • JAPAN DIABETES MARKET
        • MARKET TRENDS
      •    SOUTH KOREA
        • MARKET TRENDS
      •    INDONESIA
        • MARKET TRENDS
      •    MALAYSIA
        • MARKET TRENDS
      •    PHILIPPINES
        • MARKET TRENDS
      •    THAILAND
        • MARKET TRENDS
      •    VIETNAM
        • MARKET TRENDS
      • REST OF APAC
    •    REST OF WORLD
      •    LATIN AMERICA
        • BRAZIL HEALTH AND HEALTHCARE
        • BRAZIL PHARMACEUTICAL MARKET
        • MEXICO HEALTH AND HEALTHCARE
        • MEXICO PHARMACEUTICAL MARKET
      • MIDDLE EAST AND AFRICA
  1. COMPANY PROFILES
    • ABBOTT
    • APEX BIOTECHNOLOGY CORPORATION
    • ARKRAY INC
    • ASCENSIA
    • B BRAUN MELSUNGEN AG
    • BECTON DICKINSON AND COMPANY
    • DEXCOM
    • GLYSENS INC
    • INSULET CORP
    • I-SENS INC
    • JOHNSON AND JOHNSON
    • MEDTRONIC
    • MOREPEN LABORATORIES LTD
    • NEMAURA MEDICAL INC
    • ROCHE DIAGNOSTICS
    • SENSEONICS INC
    • TANDEM DIABETES CARE
    • TERUMO
    • WOCKHARDT
    • YPSOMED

LIST OF TABLE

TABLE 1: MARKET SNAPSHOT – GLUCOSE MONITORING SYSTEM

TABLE 2: DIABETES PREVALENCE IN VARIOUS REGION 2015-2040 (MILLIONS)

TABLE 3: GLOBAL CGMS MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 4: GLOBAL CGMS MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 5: GLOBAL SENSORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 6: GLOBAL SENSORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 7: GLOBAL TRANSMITTER AND RECEIVERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 8: GLOBAL TRANSMITTER AND RECEIVERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 9: GLOBAL INTEGRATED INSULIN PUMPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 10: GLOBAL INTEGRATED INSULIN PUMPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 11: GLOBAL CGMS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 12: GLOBAL CGMS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 13: GLOBAL HOME SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 14: GLOBAL HOME SETTINGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 15: GLOBAL DIAGNOSTICS AND CLINICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 16: GLOBAL DIAGNOSTICS AND CLINICAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 17: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 19: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 20: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 21: GLOBAL ADULT POPULATION (>14YEARS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 22: GLOBAL ADULT POPULATION (>14YEARS) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 23: GLOBAL CHILD POPULATION (≤14YEARS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 24: GLOBAL CHILD POPULATION (≤14YEARS) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 25: IMPORTANT ASPECTS FOR THE USE OF SMBG DEVICES IN HOME-CARE SETTINGS

TABLE 26: SMBG STRIPS USAGE SCENARIO IN SELECTED COUNTRIES IN AMERICAS

TABLE 27: PRODUCT MATRIX FOR LANCETS

TABLE 28: GLOBAL SMBG MARKET, BY COMPONENT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 29: GLOBAL SMBG MARKET, BY COMPONENT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 30: GLOBAL TEST STRIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 31: GLOBAL TEST STRIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 32: GLOBAL GLUCOSE METER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 33: GLOBAL GLUCOSE METER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 34: GLOBAL LANCETS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 35: GLOBAL LANCETS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 36: GLOBAL SMBG MARKET, BY END USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 37: GLOBAL SMBG MARKET, BY END USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 38: GLOBAL HOME SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 39: GLOBAL HOME SETTINGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 40: GLOBAL CLINICAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 41: GLOBAL CLINICAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 42: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 43: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 44: GLOBAL SMBG MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 45: GLOBAL SMBG MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 46: GLOBAL TYPE 1 DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 47: GLOBAL TYPE 1 DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 48: GLOBAL TYPE 2 DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 49: GLOBAL TYPE 2 DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 50: GLOBAL GESTATIONAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 51: GLOBAL GESTATIONAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 52: GLOBAL CGMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 53: GLOBAL CGMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 54: GLOBAL SMBG MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 55: GLOBAL SMBG MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 56: NORTH AMERICA CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 57: NORTH AMERICA CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 58: NORTH AMERICA SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 59: NORTH AMERICA SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 60: EUROPE CGMS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 61: EUROPE CGMS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 62: EUROPE SMBG MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 63: EUROPE SMBG MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 64: AVERAGE PRICES IN GERMANY FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE 65: GERMANY SMBG SALES CHANNEL 2019-2028 ($ MILLION)

TABLE 66: AVERAGE PRICES IN UK FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE 67: THE UNITED KINGDOM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 68: ASIA PACIFIC CGMS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 69: ASIA PACIFIC CGMS, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 70: ASIA PACIFIC SMBG, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 71: ASIA PACIFIC SMBG, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 72: AVERAGE PRICES IN CHINA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER

TABLE 73: CHINA SMBG SALES CHANNEL 2019-2028 ($ MILLION)

TABLE 74: AVERAGE PRICES IN INDIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 75: INDIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 76: AVERAGE PRICES IN AUSTRALIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 77: AUSTRALIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 78: AVERAGE PRICES IN JAPAN FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 79: JAPAN SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 80: AVERAGE PRICES IN SOUTH KOREA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 81: SOUTH KOREA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 82: AVERAGE PRICES IN INDONESIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 83: INDONESIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 84: AVERAGE PRICES IN MALAYSIA FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 85: MALAYSIA SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 86: AVERAGE PRICES IN PHILIPPINES FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 87: PHILIPPINES SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 88: AVERAGE PRICES IN THAILAND FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 89: THAILAND SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 90: AVERAGE PRICES IN VIETNAM FOR GLUCOSE TEST STRIPS, LANCETS AND GLUCOSE METER (US $)

TABLE 91: VIETNAM SMBG SALES CHANNEL, 2019-2028 ($ MILLION)

TABLE 92: REST OF WORLD CGMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 93: REST OF WORLD CGMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 94: REST OF WORLD SMBG MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 95: REST OF WORLD SMBG MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURE

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: VALUE CHAIN OF CGMS MARKET

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: GLOBAL CGMS MARKET, BY COMPONENT TYPE, IN 2019

FIGURE 7: GLOBAL CGMS MARKET, BY SENSORS, 2019-2028 (IN $ MILLION)

FIGURE 8: GLOBAL CGMS MARKET, BY TRANSMITTER AND RECEIVERS, 2019-2028 (IN $ MILLION)

FIGURE 9: GLOBAL CGMS MARKET, BY INTEGRATED INSULIN PUMPS, 2019-2028 (IN $ MILLION)

FIGURE 10: GLOBAL CGMS MARKET, BY END-USER, IN 2019

FIGURE 11: GLOBAL CGMS MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)

FIGURE 12: GLOBAL CGMS MARKET, BY DIAGNOSTICS AND CLINICAL, 2019-2028 (IN $ MILLION)

FIGURE 13: GLOBAL CGMS MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)

FIGURE 14: GLOBAL CGMS MARKET, BY DEMOGRAPHICS, IN 2019

FIGURE 15: GLOBAL CGMS MARKET, BY ADULT POPULATION (>14YEARS), 2019-2028 (IN $ MILLION)

FIGURE 16: GLOBAL CGMS MARKET, BY CHILD POPULATION (≤14YEARS), 2019-2028 (IN $ MILLION)

FIGURE 17: GLOBAL SMBG MARKET, BY COMPONENT TYPE, IN 2019

FIGURE 18: GLOBAL SMBG MARKET, BY TEST STRIPS, 2019-2028 (IN $ MILLION)

FIGURE 19: GLOBAL SMBG MARKET, BY GLUCOSE METER, 2019-2028 (IN $ MILLION)

FIGURE 20: GLOBAL SMBG MARKET, BY LANCETS, 2019-2028 (IN $ MILLION)

FIGURE 21: GLOBAL SMBG MARKET, BY END-USER, IN 2019

FIGURE 22: GLOBAL SMBG MARKET, BY HOME SETTINGS, 2019-2028 (IN $ MILLION)

FIGURE 23: GLOBAL SMBG MARKET, BY CLINICAL, 2019-2028 (IN $ MILLION)

FIGURE 24: GLOBAL SMBG MARKET, BY HOSPITAL, 2019-2028 (IN $ MILLION)

FIGURE 25: GLOBAL SMBG MARKET, BY APPLICATION, IN 2019

FIGURE 26: GLOBAL SMBG MARKET, BY TYPE 1 DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 27: GLOBAL SMBG MARKET, BY TYPE 2 DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 28: GLOBAL SMBG MARKET, BY GESTATIONAL DIABETES, 2019-2028 (IN $ MILLION)

FIGURE 29: NORTH AMERICA CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 30: NORTH AMERICA SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 31: THE UNITED STATES CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 32: THE UNITED STATES SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 33: CANADA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 34: CANADA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 35: EUROPE CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 36: EUROPE SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 37: GERMANY CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 38: GERMANY SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 39: THE UNITED KINGDOM CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 40: THE UNITED KINGDOM SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 41: FRANCE CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 42: FRANCE SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 43: RUSSIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 44: RUSSIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 45: ITALY CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 46: ITALY SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 47: BELGIUM CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 48: BELGIUM SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 49: POLAND CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 50: POLAND SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 51: REST OF EUROPE CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 52: REST OF EUROPE SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 53: ASIA PACIFIC CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 54: ASIA PACIFIC SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 55: CHINA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 56: CHINA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 57: INDIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 58: INDIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 59: AUSTRALIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 60: AUSTRALIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 61: JAPAN CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 62: JAPAN SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 63: SOUTH KOREA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 64: SOUTH KOREA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 65: INDONESIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 66: INDONESIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 67: MALAYSIA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 68: MALAYSIA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 69: PHILIPPINES CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 70: PHILIPPINES SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 71: THAILAND CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 72: THAILAND SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 73: VIETNAM CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 74: VIETNAM SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 75: REST OF APAC CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 76: REST OF APAC SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 77: REST OF WORLD CGMS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 78: REST OF WORLD SMBG MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 79: LATIN AMERICA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 80: LATIN AMERICA SMBG MARKET, 2019-2028 (IN $ MILLION)

FIGURE 81: MIDDLE EAST & AFRICA CGMS MARKET, 2019-2028 (IN $ MILLION)

FIGURE 82: MIDDLE EAST & AFRICA SMBG MARKET, 2019-2028 (IN $ MILLION)

  1. CGMS MARKET BY COMPONENT TYPE
    • SENSORS
    • TRANSMITTER AND RECEIVERS
    • INTEGRATED INSULIN PUMPS
  2. CGMS MARKET BY END-USER
    • HOME SETTINGS
    • DIAGNOSTICS AND CLINICAL
    • HOSPITAL
  3. CGMS MARKET BY DEMOGRAPHICS
    • ADULT POPULATION (>14YEARS)
    • CHILD POPULATION (≤14YEARS)
  4. SMBG MARKET OVERVIEW
  5. SMBG MARKET BY COMPONENT TYPE
    • TEST STRIPS
    • GLUCOSE METER
    • LANCETS
  6. SMBG MARKET BY END-USER
    • HOME SETTINGS
    • CLINICAL
    • HOSPITAL
  7. SMBG MARKET BY APPLICATION
    • TYPE 1 DIABETES
    • TYPE 2 DIABETES
    • GESTATIONAL DIABETES
  8. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      •    THE UNITED STATES
        • THE UNITED STATES HEALTH AND HEALTHCARE
        • THE UNITED STATES PHARMACEUTICAL MARKET
      •    CANADA
        • CANADA HEALTH AND HEALTHCARE
        • CANADA PHARMACEUTICAL MARKET
        • CANADA DIABETES MARKET
    •    EUROPE
      •    GERMANY
        • GERMANY HEALTH AND HEALTHCARE
        • GERMANY PHARMACEUTICAL MARKET
      •    THE UNITED KINGDOM
        • THE UNITED KINGDOM HEALTH AND HEALTHCARE
        • THE UNITED KINGDOM HEALTHCARE PROVISION
        • THE UNITED KINGDOM PRIVATE SECTOR INVOLVEMENT
        • THE UNITED KINGDOM PHARMACEUTICALS
      •    FRANCE
        • FRANCE HEALTH AND HEALTHCARE
        • FRANCE HEALTHCARE PROVISION
      •    RUSSIA
        • RUSSIA HEALTH AND HEALTHCARE
        • RUSSIA PHARMACEUTICAL SERVICES
      •    ITALY
        • ITALY HEALTH AND HEALTHCARE
        • ITALY HEALTHCARE PROVISION
        • ITALY PHARMACEUTICAL MARKET
      • BELGIUM
      • POLAND
      • REST OF EUROPE (ROE)
    •    ASIA PACIFIC
      •    CHINA
        • CHINA HEALTH AND HEALTHCARE
        • CHINA PHARMACEUTICAL MARKET
        • CHINA DIABETES MARKET
        • MARKET TRENDS
      •    INDIA
        • INDIA HEALTH AND HEALTHCARE
        • INDIA REGULATORY CHANGES
        • INDIA PHARMACEUTICAL MARKET
        • INDIA DIABETES MARKET
      •    AUSTRALIA
        • MARKET TRENDS
      •    JAPAN
        • JAPAN HEALTH AND HEALTHCARE
        • JAPAN PHARMACEUTICAL MARKET
        • JAPAN DIABETES MARKET
        • MARKET TRENDS
      •    SOUTH KOREA
        • MARKET TRENDS
      •    INDONESIA
        • MARKET TRENDS
      •    MALAYSIA
        • MARKET TRENDS
      •    PHILIPPINES
        • MARKET TRENDS
      •    THAILAND
        • MARKET TRENDS
      •    VIETNAM
        • MARKET TRENDS
      • REST OF APAC
    •    REST OF WORLD
      •    LATIN AMERICA
        • BRAZIL HEALTH AND HEALTHCARE
        • BRAZIL PHARMACEUTICAL MARKET
        • MEXICO HEALTH AND HEALTHCARE
        • MEXICO PHARMACEUTICAL MARKET
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type

    Buy Now